Menu
1 min read · estimated
APPROVED USE
What FDA approved
With fludarabine as conditioning before allogeneic hematopoietic stem cell transplantation in adults and children age 1 year or older with AML or myelodysplastic syndrome.
LAMPGEN ANALYSIS
Why it matters
The approval establishes a treosulfan-based conditioning option for patients with AML or MDS proceeding to allogeneic transplant.
What research teams should watch
Coordinate dosing and drug supply against the donor graft date and record conditioning deviations in the transplant schedule.
PRIMARY RECORDS